BRPI0719939A2 - Derivados de quinolina antibacterianos - Google Patents

Derivados de quinolina antibacterianos

Info

Publication number: BRPI0719939A2
Authority: BR; Brazil
Prior art keywords: quinoline derivatives; antibacterial quinoline; antibacterial; derivatives; quinoline
Prior art date: 2006-12-06

Application number

BRPI0719939-2A2A

Other languages

English (en)

Inventor

Jerome Emile Georges Guillemont

Ismet Dorange

Magali Madeleine Simone Motte

Koenraad Jozef Lodewijk Marcel Andries

Anil Koul

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-06

Filing date

2007-12-04

Publication date

2014-03-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37909392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0719939(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2007-12-04 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2014-03-11 Publication of BRPI0719939A2 publication Critical patent/BRPI0719939A2/pt

2020-11-17 Publication of BRPI0719939B1 publication Critical patent/BRPI0719939B1/pt

2021-05-25 Publication of BRPI0719939B8 publication Critical patent/BRPI0719939B8/pt

Links

SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 1
230000000844 anti-bacterial effect Effects 0.000 title 1
229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)

BRPI0719939A 2006-12-06 2007-12-04 derivado de quinolina, sua composição farmacêutica, seu uso, seu processo de preparação, combinação e produto compreendendo o mesmo BRPI0719939B8 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP06125510		2006-12-06
EP06125510.5		2006-12-06
PCT/EP2007/063314 WO2008068268A1 (en)	2006-12-06	2007-12-04	Antibacterial quinoline derivatives

Publications (3)

Publication Number	Publication Date
BRPI0719939A2 true BRPI0719939A2 (pt)	2014-03-11
BRPI0719939B1 BRPI0719939B1 (pt)	2020-11-17
BRPI0719939B8 BRPI0719939B8 (pt)	2021-05-25

Family

ID=37909392

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0719939A BRPI0719939B8 (pt)	2006-12-06	2007-12-04	derivado de quinolina, sua composição farmacêutica, seu uso, seu processo de preparação, combinação e produto compreendendo o mesmo

Country Status (31)

Country	Link
US (1)	US8293732B2 (pt)
EP (1)	EP2099760B1 (pt)
JP (1)	JP5466012B2 (pt)
KR (3)	KR101908350B1 (pt)
CN (1)	CN101547905B (pt)
AP (1)	AP2670A (pt)
AR (1)	AR064147A1 (pt)
BR (1)	BRPI0719939B8 (pt)
CA (1)	CA2668517C (pt)
CL (1)	CL2007003515A1 (pt)
CY (1)	CY1114384T1 (pt)
DK (1)	DK2099760T3 (pt)
EA (1)	EA022344B1 (pt)
ES (1)	ES2407824T3 (pt)
HR (1)	HRP20130372T1 (pt)
IL (2)	IL199078A (pt)
JO (1)	JO2970B1 (pt)
ME (1)	ME01521B (pt)
MX (1)	MX2009005979A (pt)
MY (1)	MY150411A (pt)
NO (1)	NO342095B1 (pt)
NZ (1)	NZ577128A (pt)
PL (1)	PL2099760T3 (pt)
PT (1)	PT2099760E (pt)
RS (1)	RS52753B (pt)
SG (1)	SG10201405650SA (pt)
SI (1)	SI2099760T1 (pt)
TW (1)	TWI396536B (pt)
UA (1)	UA101306C2 (pt)
WO (1)	WO2008068268A1 (pt)
ZA (1)	ZA200903946B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JO2970B1 (en) *	2006-12-06	2016-03-15	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
KR102110355B1 (ko)	2012-04-27	2020-05-14	얀센 파마슈티카 엔.브이.	항균성 퀴놀린 유도체
CA2869453C (en)	2012-04-27	2021-03-02	Janssen Pharmaceutica Nv	Antibacterial quinoline derivatives
ES2934785T3 (es) *	2016-03-07	2023-02-27	Global Alliance For Tb Drug Development Inc	Compuestos antibacterianos y usos de los mismos
US11857352B2 (en)	2016-09-06	2024-01-02	The Research Foundation For The State University Of New York	Positron imaging tomography imaging agent composition and method for bacterial infection

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5965572A (en) *	1996-10-28	1999-10-12	The United States Of America As Respresented By The Secretary Of The Army	Methods for treating antibiotic-resistant infections
US6103905A (en)	1997-06-19	2000-08-15	Sepracor, Inc.	Quinoline-indole antimicrobial agents, uses and compositions related thereto
DK1527050T3 (da) *	2002-07-25	2010-07-19	Janssen Pharmaceutica Nv	Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer
EA011277B1 (ru)	2004-01-23	2009-02-27	Янссен Фармацевтика Н.В.	Производные хинолина и их применение в качестве ингибиторов микобактерий
AP2188A (en)	2004-01-23	2010-12-14	Janssen Pharmaceutica Nv	Substituted quinolines and their use as mycobacterial inhibitors.
EA011572B9 (ru)	2004-01-29	2018-01-31	Янссен Фармацевтика Н.В.	Производные хинолина для применения в качестве микобактериальных ингибиторов
AU2005249231B2 (en) *	2004-05-28	2010-11-11	Janssen Pharmaceutica N.V.	Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
RS56357B1 (sr)	2004-09-28	2017-12-29	Janssen Pharmaceutica Nv	Vezujući domen bakterijske atp sintaze
EE05394B1 (et)	2004-12-24	2011-04-15	Janssen Pharmaceutica N.V.	Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
CA2528849C (en)	2005-06-08	2014-01-14	Janssen Pharmaceutica N.V.	Quinoline derivatives as antibacterial agents
JO2752B1 (en)	2005-06-28	2014-03-15	شركة جانسين فارماسوتيكا ان. في	Quinoline derivatives acting as antibacterial agents
AU2006263882B2 (en)	2005-06-28	2012-12-13	Janssen Pharmaceutica N.V	Quinoline derivatives as antibacterial agents
JO2970B1 (en) *	2006-12-06	2016-03-15	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
JO2683B1 (en) *	2006-12-06	2013-03-03	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives

2007
- 2007-11-29 JO JO2007505A patent/JO2970B1/en active
- 2007-12-04 EP EP07847812A patent/EP2099760B1/en active Active
- 2007-12-04 US US12/516,249 patent/US8293732B2/en active Active
- 2007-12-04 KR KR1020157031291A patent/KR101908350B1/ko active Active
- 2007-12-04 RS RS20130165A patent/RS52753B/sr unknown
- 2007-12-04 ME MEP-2013-43A patent/ME01521B/me unknown
- 2007-12-04 EA EA200970536A patent/EA022344B1/ru unknown
- 2007-12-04 ES ES07847812T patent/ES2407824T3/es active Active
- 2007-12-04 SI SI200731214T patent/SI2099760T1/sl unknown
- 2007-12-04 CA CA2668517A patent/CA2668517C/en active Active
- 2007-12-04 PT PT78478120T patent/PT2099760E/pt unknown
- 2007-12-04 JP JP2009539739A patent/JP5466012B2/ja active Active
- 2007-12-04 KR KR1020097012242A patent/KR101574642B1/ko active Active
- 2007-12-04 CN CN200780044895.7A patent/CN101547905B/zh active Active
- 2007-12-04 MY MYPI20092286 patent/MY150411A/en unknown
- 2007-12-04 MX MX2009005979A patent/MX2009005979A/es active IP Right Grant
- 2007-12-04 HR HRP20130372TT patent/HRP20130372T1/hr unknown
- 2007-12-04 AP AP2009004871A patent/AP2670A/xx active
- 2007-12-04 WO PCT/EP2007/063314 patent/WO2008068268A1/en not_active Ceased
- 2007-12-04 UA UAA200904217A patent/UA101306C2/ru unknown
- 2007-12-04 BR BRPI0719939A patent/BRPI0719939B8/pt active IP Right Grant
- 2007-12-04 DK DK07847812.0T patent/DK2099760T3/da active
- 2007-12-04 SG SG10201405650SA patent/SG10201405650SA/en unknown
- 2007-12-04 PL PL07847812T patent/PL2099760T3/pl unknown
- 2007-12-04 NZ NZ577128A patent/NZ577128A/en unknown
- 2007-12-04 KR KR1020167037101A patent/KR20170003741A/ko not_active Ceased
- 2007-12-05 AR ARP070105440A patent/AR064147A1/es unknown
- 2007-12-05 TW TW096146215A patent/TWI396536B/zh active
- 2007-12-05 CL CL200703515A patent/CL2007003515A1/es unknown
2009
- 2009-06-02 IL IL199078A patent/IL199078A/en active IP Right Grant
- 2009-06-05 ZA ZA200903946A patent/ZA200903946B/xx unknown
- 2009-07-06 NO NO20092536A patent/NO342095B1/no unknown
2013
- 2013-05-17 CY CY20131100403T patent/CY1114384T1/el unknown
2015
- 2015-09-10 IL IL241548A patent/IL241548B/en active IP Right Grant

Also Published As

Publication number	Publication date
CY1114384T1 (el)	2016-08-31
KR101574642B1 (ko)	2015-12-04
ME01521B (me)	2014-04-20
AP2009004871A0 (en)	2009-06-30
PT2099760E (pt)	2013-05-06
AR064147A1 (es)	2009-03-18
JO2970B1 (en)	2016-03-15
ES2407824T3 (es)	2013-06-14
KR20150126737A (ko)	2015-11-12
WO2008068268A1 (en)	2008-06-12
TW200838530A (en)	2008-10-01
MX2009005979A (es)	2009-06-16
MY150411A (en)	2014-01-15
DK2099760T3 (da)	2013-05-13
HRP20130372T1 (en)	2013-05-31
NZ577128A (en)	2012-01-12
CN101547905B (zh)	2015-01-28
IL199078A (en)	2015-10-29
SG10201405650SA (en)	2014-11-27
EA200970536A1 (ru)	2009-10-30
IL241548B (en)	2018-03-29
BRPI0719939B8 (pt)	2021-05-25
UA101306C2 (en)	2013-03-25
AP2670A (en)	2013-05-15
RS52753B (sr)	2013-08-30
HK1137433A1 (en)	2010-07-30
CL2007003515A1 (es)	2008-07-11
EP2099760B1 (en)	2013-02-20
KR20090090339A (ko)	2009-08-25
JP5466012B2 (ja)	2014-04-09
CA2668517C (en)	2016-01-12
IL241548A0 (en)	2015-11-30
JP2010511669A (ja)	2010-04-15
US20100029679A1 (en)	2010-02-04
TWI396536B (zh)	2013-05-21
CA2668517A1 (en)	2008-06-12
CN101547905A (zh)	2009-09-30
KR101908350B1 (ko)	2018-10-16
NO20092536L (no)	2009-08-24
PL2099760T3 (pl)	2013-07-31
SI2099760T1 (sl)	2013-06-28
BRPI0719939B1 (pt)	2020-11-17
NO342095B1 (no)	2018-03-19
ZA200903946B (en)	2010-08-25
EP2099760A1 (en)	2009-09-16
EA022344B1 (ru)	2015-12-30
AU2007328888A1 (en)	2008-06-12
KR20170003741A (ko)	2017-01-09
US8293732B2 (en)	2012-10-23

Legal Events

Date	Code	Title	Description
2018-03-20	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2018-04-24	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2020-01-28	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-02-11	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2020-06-02	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2020-09-08	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2020-11-17	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2020, OBSERVADAS AS CONDICOES LEGAIS.
2021-05-25	B16C	Correction of notification of the grant [chapter 16.3 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/12/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

Publication	Publication Date	Title
BRPI0720220A2 (pt)	2013-12-24	Derivados de quinolinas antibacterianos
EP2072519A4 (en)	2009-10-21	DIARYLKETIMINDERIVAT
ATE467619T1 (de)	2010-05-15	Antibakterielle chinolinderivate
IL188987A0 (en)	2008-08-07	Antibacterial quinoline derivatives
ATE509915T1 (de)	2011-06-15	Antibakterielle chinolinderivate
IL241548B (en)	2018-03-29	Antibacterial quinoline derivatives
ATE465994T1 (de)	2010-05-15	Antibakterielle chinolinderivate
BRPI0719915A2 (pt)	2014-03-04	Derivados de quinolina antibacterianos
DK2010202T3 (da)	2013-12-16	Antibakterielle forbindelser